|
US6858614B2
(en)
|
2002-02-19 |
2005-02-22 |
Parion Sciences, Inc. |
Phenolic guanidine sodium channel blockers
|
|
US6858615B2
(en)
|
2002-02-19 |
2005-02-22 |
Parion Sciences, Inc. |
Phenyl guanidine sodium channel blockers
|
|
US6903105B2
(en)
|
2003-02-19 |
2005-06-07 |
Parion Sciences, Inc. |
Sodium channel blockers
|
|
ES2432529T3
(es)
|
2003-08-18 |
2013-12-04 |
Parion Sciences, Inc. |
Bloqueadores del canal de sodio de pirazinoilguanidina rematada
|
|
US7375107B2
(en)
|
2003-08-18 |
2008-05-20 |
Parion Sciences, Inc. |
Alaphatic pyrazinoylguanidine sodium channel blockers
|
|
JP2007502829A
(ja)
|
2003-08-18 |
2007-02-15 |
パリオン・サイエンシィズ・インコーポレーテッド |
環状ピラジノイルグアニジンナトリウムチャネルブロッカー
|
|
US20050090505A1
(en)
|
2003-08-18 |
2005-04-28 |
Johnson Michael R. |
Methods of reducing risk of infection from pathogens
|
|
US7745442B2
(en)
|
2003-08-20 |
2010-06-29 |
Parion Sciences, Inc. |
Methods of reducing risk of infection from pathogens
|
|
US7399766B2
(en)
|
2004-08-18 |
2008-07-15 |
Parion Sciences, Inc. |
Soluble amide & ester pyrazinoylguanidine sodium channel blockers
|
|
US7807834B2
(en)
|
2005-08-03 |
2010-10-05 |
Parion Sciences, Inc. |
Capped pyrazinoylguanidine sodium channel blockers
|
|
GB0526240D0
(en)
|
2005-12-22 |
2006-02-01 |
Novartis Ag |
Organic compounds
|
|
GB0526244D0
(en)
|
2005-12-22 |
2006-02-01 |
Novartis Ag |
Organic compounds
|
|
US8288391B2
(en)
|
2007-04-03 |
2012-10-16 |
Parion Sciences, Inc. |
Pyrazinoylguanidine compounds for use as taste modulators
|
|
DE602008005140D1
(de)
|
2007-05-07 |
2011-04-07 |
Novartis Ag |
Organische verbindungen
|
|
WO2009019506A1
(en)
|
2007-08-03 |
2009-02-12 |
Astrazeneca Ab |
Heterocyclyc sulfonamides having edg-1 antagonistic activity
|
|
MX2010006421A
(es)
|
2007-12-10 |
2010-06-25 |
Novartis Ag |
Compuestos organicos.
|
|
ES2485642T3
(es)
|
2008-02-26 |
2014-08-14 |
Parion Sciences, Inc. |
Bloqueantes poli-aromáticos de los canales de sodio
|
|
CA2723938A1
(en)
|
2008-05-13 |
2009-11-19 |
Novartis Ag |
3,5-diamino-6-chloro-pyrazine-2-carboxylic acid derivatives and their use as epithelial sodium channel blockers for the treatment of airway diseases
|
|
JP2011522860A
(ja)
|
2008-06-10 |
2011-08-04 |
ノバルティス アーゲー |
上皮性ナトリウムチャネルブロッカーとしてのピラジン誘導体
|
|
WO2011028740A1
(en)
|
2009-09-03 |
2011-03-10 |
Glaxo Group Limited |
ENaC BLOCKERS
|
|
WO2011079087A1
(en)
|
2009-12-23 |
2011-06-30 |
Glaxo Group Limited |
Enac blockers
|
|
US8247436B2
(en)
|
2010-03-19 |
2012-08-21 |
Novartis Ag |
Pyridine and pyrazine derivative for the treatment of CF
|
|
US8372845B2
(en)
|
2010-09-17 |
2013-02-12 |
Novartis Ag |
Pyrazine derivatives as enac blockers
|
|
AR086745A1
(es)
|
2011-06-27 |
2014-01-22 |
Parion Sciences Inc |
3,5-diamino-6-cloro-n-(n-(4-(4-(2-(hexil(2,3,4,5,6-pentahidroxihexil)amino)etoxi)fenil)butil)carbamimidoil)pirazina-2-carboxamida
|
|
KR102006612B1
(ko)
|
2011-11-02 |
2019-08-02 |
베링거 인겔하임 인터내셔날 게엠베하 |
헤테로사이클릭 화합물, 상기 화합물을 포함하는 약제, 이의 용도, 및 이의 제조 방법
|
|
US8859559B2
(en)
|
2011-12-20 |
2014-10-14 |
Boehringer Ingelheim International Gmbh |
Substituted pyrazines and their use in the treatment of disease
|
|
HUE039734T2
(hu)
|
2012-05-29 |
2019-01-28 |
Parion Sciences Inc |
Nátriumcsatorna-blokkoló aktivitású, dendrimerszerû amino-amid-származékok száraz szem és más nyálkahártya-megbetegedések kezelésére
|
|
US8841309B2
(en)
|
2012-09-24 |
2014-09-23 |
Boehringer Ingelheim International Gmbh |
Substituted pyrazines and their use in the treatment of disease
|
|
CN108658876A
(zh)
|
2012-12-17 |
2018-10-16 |
帕里昂科学公司 |
3,5-二氨基-6-氯-n-(n-(4-苯基丁基)甲脒基)吡嗪-2-甲酰胺化合物
|
|
ES2674665T3
(es)
|
2012-12-17 |
2018-07-03 |
Parion Sciences, Inc. |
Compuestos de 3,5-diamino-6-cloro-N-(N-(4-fenilbutilo)carbamimidoilo)-pirazina-2-carboxamida
|
|
CA2895512C
(en)
|
2012-12-17 |
2021-10-19 |
Parion Sciences, Inc. |
Chloro-pyrazine carboxamide derivatives useful for the treatment of diseases favoured by insufficient mucosal hydration
|
|
EP2991981B1
(en)
|
2013-04-30 |
2017-03-01 |
Boehringer Ingelheim International GmbH |
Diaminopyrazine compounds, medicaments containing said compounds, use thereof and processes for the preparation thereof
|
|
AU2014284268A1
(en)
|
2013-07-02 |
2016-01-07 |
The California Institute For Biomedical Research |
Compounds for treatment of cystic fibrosis
|
|
EP3019492B1
(en)
|
2013-07-08 |
2017-09-06 |
Boehringer Ingelheim International GmbH |
Amiloride-type compounds as inhibitors in epithelial sodium channels for the treatment of diseases of the lungs and airways
|
|
EP3022197B1
(en)
|
2013-07-15 |
2017-09-06 |
Boehringer Ingelheim International GmbH |
Novel tetra- and pentasubstituted benzimidazolium compounds
|
|
WO2015007516A1
(en)
|
2013-07-15 |
2015-01-22 |
Boehringer Ingelheim International Gmbh |
Novel 5-substituted benzimidazolium compounds
|
|
JP6461134B2
(ja)
|
2013-07-15 |
2019-01-30 |
ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング |
新規ベンゾイミダゾリウム化合物
|
|
WO2015018754A1
(en)
|
2013-08-08 |
2015-02-12 |
Boehringer Ingelheim International Gmbh |
Novel pyrazine amide compounds
|
|
JP6847838B2
(ja)
|
2015-01-12 |
2021-03-24 |
ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング |
上皮ナトリウムチャネル阻害剤としての２−（ピラジン−２−イルカルボニルアミノメチル）ベンズイミダゾリウム化合物
|
|
EP3245199B1
(en)
|
2015-01-12 |
2020-01-01 |
Boehringer Ingelheim International GmbH |
Substituted benzimidazolium compounds useful in the treatment of respiratory diseases
|
|
WO2016113169A1
(en)
|
2015-01-12 |
2016-07-21 |
Boehringer Ingelheim International Gmbh |
Tetra- and pentasubstituted benzimidazolium compounds useful in the treatment of respiratory diseases
|
|
US9932324B2
(en)
|
2015-01-12 |
2018-04-03 |
Boehringer Ingelheim International Gmbh |
Substituted benzimidazolium compounds useful in the treatment of respiratory diseases
|
|
MX370598B
(es)
|
2015-08-20 |
2019-12-18 |
Boehringer Ingelheim Int |
Fenoxiacetamidas apareadas novedosas.
|
|
EA201890532A1
(ru)
|
2015-08-20 |
2018-09-28 |
Бёрингер Ингельхайм Интернациональ Гмбх |
Новые аннелированные бензамиды
|
|
GB201610854D0
(en)
|
2016-06-21 |
2016-08-03 |
Entpr Therapeutics Ltd |
Compounds
|
|
GB201619694D0
(en)
*
|
2016-11-22 |
2017-01-04 |
Entpr Therapeutics Ltd |
Compounds
|